Recent Advances in Nanoparticle Drug Delivery for Targeting Lymph Node -An Overview in Cancer Immunotherapy
A. A. Podutwar, S. A. Polshettiwar, A. R. Gawade, Akshay Baheti, Manish S. Wani, Mayuri Ghanekar, Asmita Gupta, Purva Chondorkar
Journal of Pharmaceutical Research International · pp. 64–74 · Published 4 Sep 2021
10.9734/jpri/2021/v33i43A32468Abstract
Generally, it is said that the lymph node plays very important role in the cancer immunotherapy. So, delivering immunomodulating compounds to lymph node can be useful strategy for cancer immunotherapy. In case of this lymph node drug delivery system, lipid nanoparticles are widely used. High amount of drugs, nucleic acids and various other compounds can easily load in lipid nanoparticle, and they are easy to be manufacture on industrial scale also. In this review, we have focused on the potential of lipid nanoparticle technology to aim lymph nodes. However, there are many factors that control the delivery of drugs to lymphatics. Before the lymphatic detection, lipid nanoformulations are necessary to go through interstitial hindrance which alters delivery of them. So, the distribution and detection of lipid nanoformulations by means of lymphatic system depend on charge present on nanoparticles, hydrophobicity, particle size and molecular weight, form & type of lipid and emulsifier concentrations are as well significant factors disturbing the delivery of drugs in the lymphatic system.
Cited by 3
Shalmali Shirish Cholkar, Ashwini Ramkrishana Gawade, Ashwin Bhanudas Kuchekar · Biosciences Biotechnology Research Asia · 2022
Karthikeyan Elumalai, Sivaneswari Srinivasan · Nano TransMed · 2025
Shalmali Shirish Cholkar, Ashwini Ramkrishana Gawade, Ashwin Bhanudas Kuchekar · Biosciences Biotechnology Research Asia · 2022
Related research
- Tumor Associated Immune Dysfunction: Immune Cells Involved and Suggested Therapies — shares topic coverage
- Oncolytic Parvoviruses: An Emerging Frontier for Targeted Gene Therapy of Human Carcinoma — shares topic coverage
- Targeting PD-1: A Computational Approach to Discover Small Molecule Inhibitors for Cancer Treatment — shares topic coverage
- Computational Identification of YQG-Like Small-molecule Inhibitors Targeting TIM-3 for Cancer Immunotherapy — shares topic coverage
- The Gut–NET–ICB Axis: Microbial Metabolite-Mediated Regulation of NETosis and Implications for Cancer Immunotherapy — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
3
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.